In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd
In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd

In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd

Establishing a strong regulatory framework and maintaining compliance with relevant regulations is paramount for success in the pharmaceutical industry, states Dr Saloni Wagh, Director of Supriya Lifescience Ltd.

Mandar Wagh Article rating: 4.6

Establishing a strong regulatory framework and maintaining compliance with relevant regulations is paramount for success in the pharmaceutical industry, states Dr Saloni Wagh, Director of Supriya Lifescience Ltd.

DSIJ MINDSHARE

Mindshare16-Jul, 2024

Mkt Commentary15-Jul, 2024

Penny Stocks16-Jul, 2024

Swing Trading16-Jul, 2024

Mindshare16-Jul, 2024

Knowledge

General9-Jul, 2024

General9-Jul, 2024

General9-Jul, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR